Blockchain Registration Transaction Record

HeartBeam to Reveal Q3 Results, Cardiac Tech Updates Nov 13

HeartBeam announces Q3 2025 conference call for Nov 13 to discuss financial results, FDA regulatory progress, and commercial readiness of revolutionary 3D ECG technology.

This development matters because HeartBeam's technology addresses critical gaps in cardiac care accessibility and monitoring. Traditional ECG systems require hospital visits and wired connections, creating barriers for patients in rural areas, those with mobility issues, and individuals needing continuous monitoring. The company's portable 3D ECG technology could enable earlier detection of heart conditions, reduce healthcare costs by minimizing unnecessary hospital visits, and potentially save lives through timely intervention. As cardiovascular disease remains the leading cause of death globally, innovations that make cardiac monitoring more accessible and comprehensive represent significant advancements in preventive healthcare and remote patient management.